RS57846B1 - Dobijanje (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida - Google Patents

Dobijanje (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida

Info

Publication number
RS57846B1
RS57846B1 RS20181236A RSP20181236A RS57846B1 RS 57846 B1 RS57846 B1 RS 57846B1 RS 20181236 A RS20181236 A RS 20181236A RS P20181236 A RSP20181236 A RS P20181236A RS 57846 B1 RS57846 B1 RS 57846B1
Authority
RS
Serbia
Prior art keywords
formula
compound
sdg
compounds
meoh
Prior art date
Application number
RS20181236A
Other languages
English (en)
Serbian (sr)
Inventor
Melpo Christofidou-Solomidou
Kyriacos C Nicolaou
Roman A Valiulin
Nicholas Simmons
Philipp M Heretsch
Original Assignee
Univ Pennsylvania
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania, Scripps Research Inst filed Critical Univ Pennsylvania
Publication of RS57846B1 publication Critical patent/RS57846B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/303—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
RS20181236A 2013-06-10 2014-06-10 Dobijanje (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida RS57846B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361833258P 2013-06-10 2013-06-10
EP14811683.3A EP3007557B1 (en) 2013-06-10 2014-06-10 Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
PCT/US2014/041636 WO2014200964A1 (en) 2013-06-10 2014-06-10 Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside

Publications (1)

Publication Number Publication Date
RS57846B1 true RS57846B1 (sr) 2018-12-31

Family

ID=52022698

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181236A RS57846B1 (sr) 2013-06-10 2014-06-10 Dobijanje (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida

Country Status (21)

Country Link
US (2) US10030040B2 (enExample)
EP (2) EP3488697A1 (enExample)
JP (3) JP6321788B2 (enExample)
KR (1) KR102270124B1 (enExample)
CN (2) CN107955046A (enExample)
AU (1) AU2014278362B2 (enExample)
CA (1) CA2920346A1 (enExample)
CY (1) CY1120759T1 (enExample)
DK (1) DK3007557T3 (enExample)
ES (1) ES2691845T3 (enExample)
HR (1) HRP20181663T1 (enExample)
HU (1) HUE040022T2 (enExample)
IL (2) IL243029B (enExample)
LT (1) LT3007557T (enExample)
PL (1) PL3007557T3 (enExample)
PT (1) PT3007557T (enExample)
RS (1) RS57846B1 (enExample)
SI (1) SI3007557T1 (enExample)
SM (1) SMT201800575T1 (enExample)
TR (1) TR201815423T4 (enExample)
WO (1) WO2014200964A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2920346A1 (en) 2013-06-10 2014-12-18 The Trustees Of The University Of Pennsylvania Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
CN107155304A (zh) * 2014-05-30 2017-09-12 宾夕法尼亚大学董事会 开环异落叶松脂素二葡糖苷(sdg)和相关化合物用于防护辐射和化学损害的用途
US20170258821A1 (en) 2014-05-30 2017-09-14 The Trustees Of The University Of Pennsylvania USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE
US11197876B2 (en) 2014-05-30 2021-12-14 The Trusiees Of The University Of Pennsylvania Effects of LGM2605 on a primate model of asthma
AU2016315952A1 (en) * 2015-09-01 2018-04-05 The Trustees Of The University Of Pennsylvania Use of secoisolariciresinol diglucosides (SDGs) and related compounds for protection against radiation damage
ES2969209T3 (es) 2016-06-07 2024-05-17 Univ Pennsylvania Composiciones y métodos para proteger órganos de lesiones por isquemia/reperfusión asociadas con el trasplante
CA3065386A1 (en) * 2017-06-12 2018-12-20 Lignamed, Llc Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
CN110283218A (zh) * 2019-06-24 2019-09-27 暨南大学 提高木酚素油溶性的改性方法
CN111233944B (zh) * 2020-03-25 2023-02-28 宝鸡市辰光生物科技有限公司 一种同时制备分离四种木脂素类成分的高效液相方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3065925B2 (ja) * 1996-01-30 2000-07-17 日清製油株式会社 活性酸素種消去剤及び退色防止剤
AU3760699A (en) * 1998-04-24 1999-11-16 Washington State University Research Foundation Recombinant secoisolariciresinol dehydrogenase, and methods of use
FI110868B (fi) * 2001-01-22 2003-04-15 Maa Ja Elintarviketalouden Tut Menetelmä sekoisolarisiresinolidiglykosidin (SDG) eristämiseksi ja puhdistamiseksi pellavansiemenistä
US20030060420A1 (en) * 2001-09-14 2003-03-27 Rick Heintzman Process for extraction and stabilization of phytoestrogens from flaxseed and product therefrom
US6806356B2 (en) * 2002-04-02 2004-10-19 Wiley Organics, Inc. Process for recovering secoisolariciresinol diglycoside from de-fatted flaxseed
JP2006347978A (ja) * 2005-06-17 2006-12-28 Nippon Flour Mills Co Ltd 抗肥満剤及びこれを含む食品並びにペットフード
JP2007308469A (ja) * 2005-11-11 2007-11-29 Nippon Flour Mills Co Ltd リグナンを有効成分とする男性用抗肥満剤
CN100395253C (zh) * 2006-05-12 2008-06-18 中国科学院山西煤炭化学研究所 一种由亚麻籽制备开环异落叶松树脂酚二葡萄糖苷的方法
CN101117641B (zh) 2007-07-27 2011-05-11 大连医诺生物有限公司 开环异落叶松树脂酚二葡萄糖苷的制备方法
JP2010057367A (ja) * 2008-09-01 2010-03-18 Nitto Boseki Co Ltd 魚肉の褐変防止剤および褐変防止方法
CN102050848A (zh) * 2009-11-01 2011-05-11 桂林莱茵生物科技股份有限公司 一种亚麻木酚素的制备方法
ES2362065B1 (es) * 2009-12-15 2012-05-18 Consejo Superior De Investigaciones Cient�?Ficas (Csic) Compuestos con actividad antiinflamatoria.
US20130203688A1 (en) * 2010-08-20 2013-08-08 Fédération Des Producteurs Acéri-Coles Du Québec Sugar plant derived by-products and methods of production thereof
CN102558252A (zh) * 2010-12-31 2012-07-11 西安天一生物技术有限公司 一种亚麻木酚素的生产工艺
CA2920346A1 (en) * 2013-06-10 2014-12-18 The Trustees Of The University Of Pennsylvania Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside

Also Published As

Publication number Publication date
US20160137682A1 (en) 2016-05-19
US20190062363A1 (en) 2019-02-28
HUE040022T2 (hu) 2019-02-28
JP2019147803A (ja) 2019-09-05
US10030040B2 (en) 2018-07-24
EP3007557B1 (en) 2018-07-18
JP2016521748A (ja) 2016-07-25
CA2920346A1 (en) 2014-12-18
EP3488697A1 (en) 2019-05-29
HRP20181663T1 (hr) 2018-12-14
SMT201800575T1 (it) 2019-01-11
PL3007557T3 (pl) 2019-04-30
JP2018111721A (ja) 2018-07-19
TR201815423T4 (tr) 2018-11-21
JP6321788B2 (ja) 2018-05-09
EP3007557A1 (en) 2016-04-20
AU2014278362B2 (en) 2017-07-13
LT3007557T (lt) 2018-11-12
CY1120759T1 (el) 2019-12-11
ES2691845T3 (es) 2018-11-28
HK1223792A1 (zh) 2017-08-11
CN105705018A (zh) 2016-06-22
SI3007557T1 (sl) 2018-12-31
KR102270124B1 (ko) 2021-06-25
AU2014278362A1 (en) 2016-02-04
JP6785335B2 (ja) 2020-11-18
PT3007557T (pt) 2018-11-09
CN107955046A (zh) 2018-04-24
US10870670B2 (en) 2020-12-22
EP3007557A4 (en) 2017-01-18
IL269622A (en) 2019-11-28
IL243029B (en) 2019-09-26
WO2014200964A1 (en) 2014-12-18
DK3007557T3 (en) 2018-11-05
JP6513853B2 (ja) 2019-05-15
KR20160023770A (ko) 2016-03-03
CN105705018B (zh) 2018-01-12

Similar Documents

Publication Publication Date Title
US10870670B2 (en) Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside
EP4406953A1 (en) 2,6-piperidinedione compound and application thereof
DD299178A5 (de) 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung, diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel
CN107266483B (zh) 一种响应过氧化氢杀灭肿瘤细胞的光敏感靶向抗肿瘤前药及其制备方法与应用
Szymańska et al. Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin
JP2004536132A (ja) 新規なet−743の抗腫瘍性誘導体
JPS58116458A (ja) 23−デヒドロ−25−ヒドロキシビタミンd↓3化合物
JP2009298731A (ja) 酸化傷害を抑制する金属ポルフィリン錯体、及びそれを用いた医薬組成物
CN114426538A (zh) 一种小檗碱卡格列净衍生物及其制备方法和应用
HK40009219A (en) Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
DE69702158T2 (de) Carnitine-Bisalkanoylester mit bakterizider, fungizider und antiprotozoischer Wirkung
HK1223792B (en) Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
AU701346B2 (en) Thiamorphinans with neuroprotective activity
CN121974839A (zh) 一种硒代七甲川吲哚花菁化合物及其制备方法和应用
Militsopoulou et al. Synthetic studies towards the development of psoralen-acidic retinoid conjugates and hybrids
WO2025086855A1 (zh) 一类叠氮前药化合物、制备方法及其应用
WO2025097160A1 (en) Methods of enhancing levodopa therapeutic efficacy
Chen et al. Design, Synthesis, and Biological Evaluation of Novel Tetramethylpyrazine-nitrone Derivatives as Antioxidants
DE1927908C3 (de) Verfahren zur Herstellung von A4·20·22 -Bufatrienolidrhamnosid- 3'-acylaten, einige dieser Verbindungen sowie diese enthaltende Arzneimittel
EP3254679A1 (de) Wirkstoffe gegen protozoen und bakterien
WO2002067929A1 (de) Furanfettsauren zur steigerung der effizienz der zytotstatika-therapie und/oder bestrahlungstherapie
JPH02152980A (ja) ジテルペン化合物